William J. Regan, SVP-Global Reg Affairs&Quality at NAVIDEA BIOPHARMACEUTICALS, INC. (NAVB), bought 5,000 shares at $1.43 ($7K) on 2014-05-12, disclosed to the SEC on 2014-05-15.
Open-market purchase of $7k NAVB by SVP-Global Reg Affairs&Quality. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.43 | 100 | $143 | 2.0% |
| 2 | $1.43 | 500 | $715 | 10.0% |
| 3 | $1.43 | 4,400 | $6K | 88.0% |
| Total | $1.43 avg | 5,000 | $7K | 100% |
| Filing → |